RECRUITING

Ketamine Treatment Plans for Chronic Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

Official Title

Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions

Quick Facts

Study Start:2023-01-01
Study Completion:2029-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06038409

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Ed Lesofski
CONTACT
406-465-9504
ed@riverofchange.org
James Taggart, MD
CONTACT
415-713-6654
jrtaggartmd@aol.com

Principal Investigator

Edward Lesofski, MS
STUDY_DIRECTOR
RIVER Foundation

Study Locations (Sites)

RIVER Telehealth
Helena, Montana, 59601
United States

Collaborators and Investigators

Sponsor: RIVER Foundation

  • Edward Lesofski, MS, STUDY_DIRECTOR, RIVER Foundation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-01
Study Completion Date2029-06-01

Study Record Updates

Study Start Date2023-01-01
Study Completion Date2029-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Pain
  • Depressive Disorder
  • Anxiety Disorders
  • Chronic Disease